首页> 外文期刊>Journal of Immunological Methods >Assessment of positivity in immuno-assays with variability in background measurements: a new approach applied to the antibody response to Plasmodium falciparum MSP2.
【24h】

Assessment of positivity in immuno-assays with variability in background measurements: a new approach applied to the antibody response to Plasmodium falciparum MSP2.

机译:免疫测定中阳性的评估以及背景测量中的变异性:一种新方法应用于对恶性疟原虫MSP2的抗体反应。

获取原文
获取原文并翻译 | 示例
           

摘要

Measurements of immune responses often exhibit considerable heterogeneity, making it impossible to clearly distinguish responders and nonresponders to particular antigens. Typically, in, for example, enzyme-linked immunosorbent assay (ELISA) procedures, a nonexposed control group is used to assign a cutoff value of positivity, calculated as the mean plus either 2 or 3 standard deviations (S.D.). This can cause extremely biased estimates of response rates when the background is variable, and especially when there is overlap between the distribution of the control levels and that of responders. This problem is compounded when results of assays with different background levels are compared. We illustrate this with hypothetical data sets reflecting frequent patterns seen in laboratory and epidemiological studies.We propose that such data should be analysed by statistical modelling of the ratio of numbers of test samples/control samples as a function of the readout from the assay. Rather than classifying samples dichotomously as negative or positive, this provides estimates of the prevalence of positivity lambda, and the probability, for each sample, that the measured activity is above background. Several statistical methods can provide such estimates. Analyses of simulated data sets using our preferred estimation method [a latent class model (LCM)] demonstrate that this gives more reliable results than the traditional assignment using cutoff values. We have applied this approach to the analysis of ELISA assessments of antibodies against distinct regions of the Plasmodium falciparum merozoite surface protein 2 (MSP2) in human sera from Tanzania.
机译:免疫反应的测量结果通常表现出相当大的异质性,因此无法清楚地区分对特定抗原的反应者和非反应者。通常,在例如酶联免疫吸附测定(ELISA)程序中,使用未暴露的对照组来确定阳性的截断值,该截断值计算为平均值加上2或3个标准差(S.D.)。当背景可变时,尤其是在控制水平的分布与响应者的分布重叠时,这可能会导致响应率的估计有很大偏差。当比较具有不同背景水平的测定结果时,这个问题变得更加复杂。我们用反映实验室和流行病学研究中常见模式的假设数据集对此进行说明。我们建议应通过对试验样品/对照样品的数量之比作为测定读数的函数进行统计建模来分析此类数据。而不是将样品一分为二地分为阴性或阳性,这提供了对λ阳性率的估计,以及每个样品测得的活性高于背景的概率。几种统计方法可以提供这种估计。使用我们的首选估计方法[潜在类模型(LCM)]对模拟数据集进行分析,结果表明,与使用截止值的传统分配相比,此方法可提供更可靠的结果。我们已将该方法用于针对坦桑尼亚人血清中恶性疟原虫裂殖子表面蛋白2(MSP2)不同区域的抗体的ELISA评估分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号